MedTrace Logo

Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment

NCT02745600 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-04-22

No results posted yet for this study

Summary

The main objective of the project is to bring the existing radio frequency ablation (RFA) model for liver cancer treatment (Project IMPPACT, Grant No. 223877, completed in February 2012) into clinical practice. Therefore the project will pursue the following objectives:

i) to prove and refine the RFA model in a small clinical study; ii) to develop the model into a real-time patient specific RFA planning and support system for Interventional Radiologists (IR) under special consideration of their clinical workflow needs; iii) to establish a corresponding training procedure for IR's; iv) to evaluate the clinical practicality and benefit of the model for use in the routine workflow in a user survey and expert forum.

Conditions

Interventions

DEVICE

RFA therapy simulator

Computer assisted RFA of liver tumors: Planning, simulation, and follow up,

Sponsors & Collaborators

  • Medical University of Graz

    collaborator OTHER

  • University Medical Center Nijmegen

    collaborator OTHER

  • University of Turku

    collaborator OTHER

  • University of Leipzig

    lead OTHER

Principal Investigators

  • Michael Moche, M.D. · Department of Diagnostic and Interventional Radiology, University Leipzig, Leipzig, Germany

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-02-28
Completion
2017-03-31

Countries

  • Austria
  • Finland
  • Germany
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02745600 on ClinicalTrials.gov